The Differential Diagnosis and Treatment of Atypical Parkinsonism

被引:156
作者
Levin, Johannes [3 ]
Kurz, Alexander [4 ]
Arzberger, Thomas [6 ]
Giese, Armin [5 ]
Hoeglinger, Guenter U. [1 ,2 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, Feodor Lynen Str 17, D-81377 Munich, Germany
[2] German Ctr Neurodegenerat Dis DZNE, Chair Translat Neurodegenerat, Munich, Germany
[3] Univ Munich, Dept Neurol, German Ctr Neurodegenerat Dis ZNE, D-80539 Munich, Germany
[4] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, Feodor Lynen Str 1, D-81377 Munich, Germany
[5] Univ Munich, Ctr Neuropathol & Prion Res ZNP, Munich, Germany
[6] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2016年 / 113卷 / 05期
关键词
PROGRESSIVE SUPRANUCLEAR PALSY; MULTIPLE-SYSTEM ATROPHY; CORTICOBASAL DEGENERATION; LEWY BODIES; ALZHEIMERS-DISEASE; DEMENTIA; CRITERIA;
D O I
10.3238/arztebl.2016.0061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Aside from idiopathic Parkinson syndrome (Parkinson's disease), there are a number of other, so-called atypical parkinsonian syndromes: dementia with Lewy bodies (DLB), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). DLB is a common disease, with a prevalence of 0.4% (400 cases per 100 000 persons) in the elderly; MSA and PSP both have a prevalence of 5 to 10 per 100 000 persons, while the prevalence of CBD is about 1 per 100 000. Methods: This review is based on pertinent publications retrieved by a selective literature search. Results: The atypical parkinsonian syndromes are synucleinopathies and tauopathies, i.e., disorders characterized by the abnormal deposition of the proteins a-synuclein and tau. The site of deposition is correlated with the clinical features. In DLB, synuclein is mainly deposited in neocortical neurons, with some brain stem involvement as well. The main clinical features are dementia and, later on, parkinsonism. In MSA, synuclein is deposited in oligodendrocytes, mainly in the cerebellum but also in the brain stem; the main clinical feature is autonomic dysfunction combined with parkinsonism or cerebellar ataxia. Synucleinopathies often impair REM (rapid eye movement) sleep. PSP and CBD, on the other hand, are primary tauopathies. PSP usually causes predominantly supranuclear vertical gaze palsy and early postural instability with falls, less commonly parkinsonism (PSP-P) or frontotemporal dementia (PSP-FTD) as its most prominent feature. CBD typically manifests itself as markedly asymmetrical parkinsonism with apraxia or cortical sensory disturbance. At present, there is no accepted causal treatment for any of these disorders; the available symptomatic treatments are of limited efficacy and are supported only by low-level evidence. Conclusion: Causal treatments for neurodegenerative diseases are now being developed and tested, and thus a molecular diagnosis is desirable. This will require the cooperation of primary care physicians with specialized centers.
引用
收藏
页码:61 / +
页数:10
相关论文
共 30 条
[1]   Criteria for the diagnosis of corticobasal degeneration [J].
Armstrong, Melissa J. ;
Litvan, Irene ;
Lang, Anthony E. ;
Bak, Thomas H. ;
Bhatia, Kailash P. ;
Borroni, Barbara ;
Boxer, Adam L. ;
Dickson, Dennis W. ;
Grossman, Murray ;
Hallett, Mark ;
Josephs, Keith A. ;
Kertesz, Andrew ;
Lee, Suzee E. ;
Miller, Bruce L. ;
Reich, Stephen G. ;
Riley, David E. ;
Tolosa, Eduardo ;
Troester, Alexander I. ;
Vidailhet, Marie ;
Weiner, William J. .
NEUROLOGY, 2013, 80 (05) :496-503
[2]   Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model [J].
Castillo-Carranza, Diana L. ;
Guerrero-Munoz, Marcos J. ;
Sengupta, Urmi ;
Hernandez, Caterina ;
Barrett, Alan D. T. ;
Dineley, Kelly ;
Kayed, Rakez .
JOURNAL OF NEUROSCIENCE, 2015, 35 (12) :4857-4868
[3]   Levodopa responsiveness in disorders with parkinsonism: A review of the literature [J].
Constantinescu, Radu ;
Richard, Irene ;
Kurlan, Roger .
MOVEMENT DISORDERS, 2007, 22 (15) :2141-2148
[4]  
Dickson D. W., 2012, COLD SPRING HARB PER, V2
[5]   Amyloid PET Imaging in Lewy Body Disorders [J].
Donaghy, Paul ;
Thomas, Alan J. ;
O'Brien, John T. .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 23 (01) :23-37
[6]  
Eggert KM, 2012, Leitlinien fur Diagnostik und Therapie in der Neurologie
[7]   Multiple-System Atrophy REPLY [J].
Fanciulli, Alessandra ;
Wenning, Gregor K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (14) :1375-1376
[8]   How to diagnose dementia with Lewy bodies: State of the art [J].
Geser, F ;
Wenning, GK ;
Poewe, W ;
McKeith, I .
MOVEMENT DISORDERS, 2005, 20 :S11-S20
[9]   Second consensus statement on the diagnosis of multiple system atrophy [J].
Gilman, S. ;
Wenning, G. K. ;
Low, P. A. ;
Brooks, D. J. ;
Mathias, C. J. ;
Trojanowski, J. Q. ;
Wood, N. W. ;
Colosimo, C. ;
Duerr, A. ;
Fowler, C. J. ;
Kaufmann, H. ;
Klockgether, T. ;
Lees, A. ;
Poewe, W. ;
Quinn, N. ;
Revesz, T. ;
Robertson, D. ;
Sandroni, P. ;
Seppi, K. ;
Vidailhet, M. .
NEUROLOGY, 2008, 71 (09) :670-676
[10]   Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia [J].
Jellinger, Kurt A. .
NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) :118-121